The E.G. Scan™ II Esophagoscope System is intended for use in endoscopic access and examination of the larynx, esophagus and gastroesophageal junction.
Device Story
E.G. Scan™ II Esophagoscope System is a transnasal endoscopic system for diagnostic visualization. The system comprises a disposable esophagoscope probe, a controller, and E.G. View™ software. The probe captures images of the larynx, esophagus, and gastroesophageal junction, transmitting data to the controller for processing and upload. The controller outputs the processed image data to the E.G. View™ software, which displays the images for clinical diagnosis. The device is intended for use by healthcare professionals in a clinical setting. By providing direct visualization of the esophageal tract, the system assists clinicians in identifying esophageal diseases, facilitating diagnostic decision-making and patient management.
Clinical Evidence
Bench testing only. Biocompatibility testing (cytotoxicity, sensitization, and irritation) performed per ISO 10993-1. Electrical safety and EMC testing performed per IEC 60601-1, IEC 60601-2-18, and IEC 60601-1-2.
Technological Characteristics
Transnasal esophagoscope system. Disposable probe. Components include probe, controller, and E.G. View™ software. Conforms to IEC 60601-1 (general safety), IEC 60601-2-18 (endoscopic equipment safety), and IEC 60601-1-2 (EMC). Patient contact parts tested for biocompatibility per ISO 10993-1.
Indications for Use
Indicated for endoscopic access and examination of the larynx, esophagus, and gastroesophageal junction in patients requiring such diagnostic procedures.
Regulatory Classification
Identification
An esophagoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the esophagoscope and is intended to examine or treat esophageal malfunction symptoms, esophageal or mediastinal disease, or to remove foreign bodies from the esophagus. When inserted, the device extends from the area of the hypopharynx to the stomach. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the flexible foreign body claw, flexible biopsy forceps, rigid biopsy curette, flexible biopsy forceps and flexible biopsy curette, but excludes the fiberoptic light source and carrier.
Modified Flexible Trans-Nasal Esophagoscope with Digital Video Processor and Disposable EndoSheath® System (K072088)
Related Devices
K131131 — E.G. SCAN(TM) II ESOPHAGOSCOPE SYSTEM · Intromedic Co., Ltd. · Jun 21, 2013
K111030 — E.G. SCAN (TM) ESOPHAGOSCOPE SYSTEM · Intromedic Co., Ltd. · Oct 21, 2011
K072088 — FLEXIBLE TRANS-NASAL VIDEO ESOPHAGOSCOPE WITH DIGITAL VIDEO PROCESSOR AND DISPOSABLE ENDOSHEATH SYSTEMS · Vision-Sciences, Inc. · Aug 29, 2007
K071153 — GIVEN DIAGNOSTIC SYSTEM WITH PILLCAM ESO2 CAPSULE · Given Imaging , Ltd. · Jun 11, 2007
K213606 — EvoEndo Single-Use Endoscopy System · EvoEndo, Inc. · Feb 14, 2022
Submission Summary (Full Text)
{0}------------------------------------------------
120702
JUN 2 0 2012
510/lx) Submission -- E.G. Scan™ II Esophagoscope System
# 5′10(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.
Date: Dec. 06. 2011
1. Company and Correspondent making the submission:
Name - IntroMedic Co., Ltd.
Address ~ Suite 1104, E&C Venture Dream Tower 6-Cha, 197-28 Guro-Dong, Guro-Gu,
Seoul, 152-719 Korea
Telephone - +82-2-801-9300
Fax – +82-2-801-9330
Contact - JinYoung, Lee
Internet – http://www.intromedic.com
- 2. Device :
| <b>Proprietary name</b> | : E.G. Scan™ II Esophagoscope System |
|----------------------------|--------------------------------------|
| <b>Common Name</b> | : Esophagoscope System |
| <b>Classification Name</b> | : Esophagoscope System |
3. Predicate Device :
| Manufacturer : | IntroMedic Co., Ltd, |
|-----------------|---------------------------------|
| Device : | E.G. Scan™ Esophagoscope System |
| 510(k) Number : | K111030 |
| Manufacturer | : Vision-Science, Inc. |
|---------------|--------------------------------------------------------------------------------------------------------------------|
| Device | : Modified Flexible Trans-Nasal Esophagoscope with<br>Digital Video Processor and Disposable EndoSheath®<br>System |
| 510(k) Number | : K072088 |
4. Classifications Names & Citations :
. 21CFR874.4710, EOX, Esophagoscope System, Class2
IntroMedic Co., Ltd.
{1}------------------------------------------------
## 510(k) Submission - E.G. Scan™ II Esophagoscope System
5. Description :
#### 5.1 Introduction
E.G. Scan™ II Esophagoscope System and its accessories are used for diagnosis of patients. E.G. Scan™ II Probe takes pictures of the esophagus of human and sends image data to E.G. Scan™ II Controller. E.G. Scan™ II Controller processes and converts image data and upload. E.G. View™ image displaying software displays the image for diagnosis.
The E.G Scan™ II Esophagoscope Probe is disposable.
#### 5.2 General Technology
E.G. Scan™ II Esophagoscope system is a transnasal esophagoscope designed to capture images of the esophagus. Captured images are viewed via the E.G. View™ Software for diagnosis of diseases related to the esophagus.
- 6. Indication for use :
The E.G. Scan™ II Esophagoscope System is intended for use in endoscopic access and examination of the larynx, esophagus and gastroesophageal junction.
- 7. Comparison with predicate device :
The E.G. Scan™ II Esophagoscope System and predicate device are substantially equivalent in the areas of design, indication for use, technological characteristics, function, application and safety and effectiveness. This was determined by reviewing the information provided in the 510(k) in comparison to the content specified in the FDA guidance documents.
## 8. Safety, EMC and Performance Data :
The E.G. Scan™ II Esophagoscope System has the same device characteristics as the predicate device, E.G. Scan™ Esophagoscope System of IntroMedic Co., Ltd.; intended use, material, design and use concept are similar. The biocompatibility of the patient contact parts has been demonstrated through the cytotoxicity, sensitization and irritation testing by ISO 10993-1 Biological evaluation of medical devices. The E.G. Scan™ II Esophagoscope System conforms to IEC 60601-1 Medical electric equipment, Part 1: General requirements for safety, IEC 60601-2-18
IntroMedic Co., Ltd.
{2}------------------------------------------------
K120702
# 510(k) Submission ~ E.G. Scan™ II Esophagoscope System
Medical electrical equipment-Part 2: Particular requirements for the safety of endoscopic equipment and IEC 60601-1-2 Medical electric equipment, General requirements for safety collateral standard electromagnetic compatibility.
#### 9. Conclusions :
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification IntroMedic Co., Ltd. concludes that The E.G. Scan™ II Esophagoscope System is safe and effective and substantially equivalent to predicate devices as described herein.
IntroMedic Co., Ltd.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a stylized eagle with three stripes representing the three branches of government. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" written around the perimeter of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
IntroMedic Company, Limited % Mr. Marc M. Mouser Underwriters Laboratories, Inc. 2600 NW Lake Road Camas, WA 98607
JUN 2 0 2012
Re: K120702
Trade/Device Name: E.G. Scan™ II Esophagoscope System Regulation Number: 21 CFR 874.4710 Regulation Name: Esophagoscope (flexible or ridgid) and accessories Regulatory Class: II Product Code: EOX Dated: May 25, 2012 Received: June 1. 2012
Dear Mr. Mouser:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
{4}------------------------------------------------
Page 2 – Mr. Marc M. Mouser
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
E. E. Ivanov
Malvina B. Eydelman M.D. Director Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices Office of Device Evaluation Health Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
K120702
# Indications for Use
510(k) Number(if known):
Device Name: E.G. Scan™ II Esophagoscope System
Indications for Use:
E.G. Scan™ II Esophagoscope System is intended for use in endoscopic access and examination of the larynx, esophagus and gastroesophageal junction.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use_ (Part 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation(ODE)
Page 1 of 1
S.M. Mofizur
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number_
× Prescription Use (Per 21 CFR 801.109)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.